Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 2, 2011, Pages 221-226

  Matera, Maria G ^a   Calzetta, Luigino ^b,c   Rogliani, Paola ^c   Bardaro, Floriana ^c   Page, Clive P ^b   Cazzola, Mario ^c,d  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Enantiomers; Equine isolated bronchi; RAO; Salbutamol

Indexed keywords

CARBACHOL; HISTAMINE; PAPAVERINE; SALBUTAMOL;

AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS; CHOLINERGIC ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENANTIOMER; FEMALE; HORSE; ISOLATION PROCEDURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RACEMIC MIXTURE; RECURRENT AIRWAY OBSTRUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION;

ALBUTEROL; ANIMALS; BRONCHI; BRONCHODILATOR AGENTS; FEMALE; HISTAMINE; HORSE DISEASES; HORSES; LUNG DISEASES, OBSTRUCTIVE; MALE; MODELS, STATISTICAL; MUSCLE CONTRACTION; MUSCLE, SMOOTH; STEREOISOMERISM;

EID: 79951945911     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2010.12.008     Document Type: Article

References (30)

1. 2-agonists in the treatment of asthma. Ther Adv Respir Dis 2007, 1:35-46.
2. Page C.P., Morley J. Contrasting properties of albuterol stereoisomers. J Allergy Clin Immunol 1999, 104:S31-S41.
3. Gupta M.K., Singh M. Evidence based review on levosalbutamol. Indian J Pediatr 2007, 74:161-167.
4. Perrin F.M., Blum P.S., Morley J., Grosclaude M., Chambe M.T. Differential responses of asthmatic airways to enantiomers of albuterol. Implications for clinical treatment of asthma. Clin Rev Allergy Immunol 1996, 14:139-147.
5. Spitzer W.O., Suissa S., Ernst P., Horwitz R.I., Habbick B., Cockcroft D., et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992, 326:501-506.
6. Agrawal D.K., Ariyarathna K., Kelbe P.W. (S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells. J Allergy Clin Immunol 2004, 113:503-510.
7. 2 agonist isomers. Expert Opin Investig Drugs 1998, 7:1601-1616.
8. Robinson N.E., Derksen F.J., Olszewski M.A., Buechner-Maxwell V.A. The pathogenesis of chronic obstructive pulmonary disease of horses. Br Vet J 1996, 152:283-306.
9. Matera M.G., Amorena M., Lucisano A. Innervation of equine airways. Pulm Pharmacol Ther 2002, 15:503-511.
10. 2-adrenergic receptors. Clin Rev Allergy Immunol 1996, 14:37-45.
11. 2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Drugs 2005, 65:1595-1610.
12. 2-adrenoceptor activation augments acetylcholine release from tracheal parasympathetic nerves. Am J Physiol 1995, 268:L950-L956.
13. 2-adrenoceptor distribution within equine airway cholinergic nerves. Respir Physiol 1996, 106:81-90.
14. 2-agonists on ACh release and smooth muscle contraction in the trachea. Am J Physiol 1998, 274:L32-L38.
15. Mitra S., Ugur M., Ugur O., Goodman H.M., McCullough J.R., Yamaguchi H. (S)-albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol 1998, 53:347-354.
16. Van Amsterdam R.G., Meurs H., Brouwer F., Postema J.B., Timmermans A., Zaagsma J. Role of phosphoinositide metabolism in functional antagonism of airway smooth muscle contraction by β-adrenoceptor agonists. Eur J Pharmacol 1989, 172:175-183.
17. 2-adrenoceptor in bovine tracheal smooth muscle. Eur J Pharmacol 2006, 529:151-156.
18. Johansson F., Rydberg I., Aberg G., Andersson R.G. Effects of albuterol enantiomers on in vitro bronchial reactivity. Clin Rev Allergy Immunol 1996, 14:57-64.
19. Abraham G., Kottke C., Dhein S., Ungemach F.R. Agonist-independent alteration in β-adrenoceptor-G-protein-adenylate cyclase system in an equine model of recurrent airway obstruction. Pulm Pharmacol Ther 2006, 19:218-229.
20. 2+ signalling and contraction of airway smooth muscle by cyclic AMP-dependent mechanisms. Br J Pharmacol 1996, 117:419-426.
21. Hoshiko K., Morley J. Exacerbation of airway hyperreactivity by (+/-)salbutamol in sensitized guinea pig. Jpn J Pharmacol 1993, 63:159-163.
22. 2-selective sympathomimetics. Pulm Pharmacol 1994, 7:367-376.
23. Abraha D., Cho S.H., Agrawal D.K., Park J.M., Oh C.K. (S, S)-formoterol increases the production of IL-4 in mast cells and the airways of a murine asthma model. Int Arch Allergy Immunol 2004, 133:380-388.
24. Cho S.H., Hartleroad J.Y., Oh C.K. (S)-albuterol increases the production of histamine and IL-4 in mast cells. Int Arch Allergy Immunol 2001, 124:478-484.
25. Baramki D., Koester J., Anderson A.J., Borish L. Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer. J Allergy Clin Immunol 2002, 109:449-454.
26. Watson N., Bodtke K., Coleman R.A., Dent G., Morton B.E., Rühlmann E., et al. Role of IgE in hyperresponsiveness induced by passive sensitization of human airways. Am J Respir Crit Care Med 1997, 155:839-844.
27. Scott J.S., Broadstone R.V., Derksen F.J., Robinson N.E. β-adrenergic blockade in ponies with recurrent obstructive pulmonary disease. J Appl Physiol 1988, 64:2324-2328.
28. Hare J.E., Viel L. Pulmonary eosinophilia associated with increased airway responsiveness in young racing horses. J Vet Intern Med 1998, 12:163-170.
29. Wong D.M., Buechner-Maxwell V.A., Manning T.O., Ward D.L. Comparison of results for intradermal testing between clinically normal horses and horses affected with recurrent airway obstruction. Am J Vet Res 2005, 66:1348-1355.
30. Deaton C.M., Deaton L., Jose-Cunilleras E., Vincent T.L., Baird A.W., Dacre K., et al. Early onset airway obstruction in response to organic dust in the horse. J Appl Physiol 2007, 102:1071-1077.